Scientific Brief, 17 June 2020
Глобальный доклад о туберкулезе ВОЗ призван дать всеобъемлющую и актуальную оценку эпидемии туберкулеза (ТБ) и достижений в области его лечения и профилактики на ...лобальном, региональном и страновом уровняхi. Такая оценка проводится в контексте рекомендованных глобальных стратегий по борьбе с ТБ и связанных с ними целевых показателей, а также более широких целей в области развития.
more
Наряду с тщательным тестированием, изоляцией и уходом за заболевшими отслеживание контактов является ведущей стратегией для прерывания цепочек передачи вируса SA...RS-CoV -2 и снижения смертности, связанной с COVID-19.
more
В документах попозиции ВОЗ обобщается основная информация о болезнях и вакцинах и в заключении излагается текущая позиция ВОЗ относительно их использования в гло...бальном контексте.
more
Welcome to our implementation research case example focusing on chagas disease and Ecuador. This module offers a comprehensive exploration of the strategies employed to address the challenges posed by Chagas disease, a neglected tropical disease prevalent in Latin America. With a specific focus on t...he southern Ecuador context, this course describes the relationship between public health interventions, socioeconomic factors, and community understanding, all of which are essential for the prevention, treatment, and diagnosis of chagas disease
more
Efficacious antimalarial medicines are critical to malaria control and elimination. Continuous monitoring of their efficacy is needed to inform treatment policies in malaria-endemic countries, and to ensure early detection of, and response to, drug resistance.
On a need’s basis, the Immunization Analysis and Insights, Vaccine Preventable Diseases (VPD) Surveillance and Risk Assessment Team of the World Health Organization (WHO) posts expression of interest (EOI) calls, inviting manufacturers of specified technologies (in vitro diagnostics also known as ...IVDs) to participate in a WHO product evaluation. The focus is on IVDs that are used by WHO’s laboratory networks undertaking surveillance for certain VPDs
more
This report explores the intersection of tuberculosis (TB) and climate change, highlighting how climate-related challenges such as food and water insecurity, displacement, and disrupted healthcare access amplify TB risk. Intended as a resource for policymakers, researchers, development partners, fin...ancing institutions, and civil society, it advocates for recognizing TB as a climate-sensitive disease. The report promotes research, calls for increased financing, and provides an evidence-based framework to inform mitigation, adaptation, and resilience strategies in the global TB response.
more
This document is for public health specialists, health emergency responders, clinicians, health facility managers, health and care workers and IPC practitioners including but not limited to those working in primary care clinics, sexual health clinics, emergency departments, dental practices, infecti...ous diseases clinics, genitourinary clinics, maternity services, paediatrics, obstetrics and gynaecology and acute care facilities that provide care for patients with suspected or confirmed mpox.
more
2nd edition. This second edition builds on the experience of more than 10 years of SMC deployment, and reflects changes introduced in the WHO guidelines for malaria, 3 June 2022. The goal of this publication is to share these best practices to improve SMC implementation, coverage, and monitoring and... evaluation. Examples of materials and tools as well as links to resources are included to support managers and health workers in their efforts to conduct successful SMC activities and prevent malaria among vulnerable children.
more
Relapsing malaria caused by Plasmodium vivax parasites poses a significant challenge to global malaria elimination efforts. About one third of the population remains at risk of contracting P. vivax malaria, and 85% of P. vivax infections stem from reactivated latent parasites, leading to chronic ana...emia and increased morbidity and mortality. In addition to diagnostic tools that can detect the acute, blood-stage of P. vivax, new tools are needed to detect the dormant infections before they reactivate and contribute to morbidity and onwards transmission
more
Meeting report, Kampala, Uganda,
7–8 November 2023
Launch of the WHO Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010–2019). Key findings
The presentation titled "Malaria Capacity Building Initiative" outlines efforts led by the WHO and partner organizations to strengthen the skills and systems needed to fight malaria globally. It highlights the need for a coordinated, long-term strategy to build human resource capacity in malaria-end...emic countries—especially among national malaria control programs, frontline health workers, NGOs, and WHO staff. The document reviews past and current training activities, such as workshops on case management, entomology, vector control, epidemiology, and planning. It emphasizes the development of standardized training materials and competency frameworks, the role of national and regional training centers, and the use of blended learning methods (e.g., e-learning and in-person sessions). The goal is not just to deliver training, but to build sustainable capacity through partnerships, continuous improvement, quality assurance, and integration into health systems. It also calls for better coordination, tracking of trained personnel, and engagement of ministries of finance to ensure long-term support.
more